Document Detail

Cryoballoon ablation of atrial fibrillation: state of the art 10 years after its invention.
MedLine Citation:
PMID:  20874670     Owner:  NLM     Status:  MEDLINE    
The present review will discuss the technical aspects of a new patent invented in 1999 which allows cryoballoon ablation, an emerging technology used for the non pharmacological treatment of paroxysmal atrial fibrillation. A general evaluation of the safety and the reliability of the technique will be given together with an overview on its short and midterm outcome. Finally future directions of the technology and its possible implementation will be briefly treated.
Antonio Sorgente; Gian Battista Chierchia; Carlo de Asmundis; Lucio Capulzini; Andrea Sarkozy; Pedro Brugada
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Recent patents on cardiovascular drug discovery     Volume:  5     ISSN:  2212-3962     ISO Abbreviation:  Recent Pat Cardiovasc Drug Discov     Publication Date:  2010 Nov 
Date Detail:
Created Date:  2010-10-15     Completed Date:  2011-02-22     Revised Date:  2011-11-10    
Medline Journal Info:
Nlm Unique ID:  101263805     Medline TA:  Recent Pat Cardiovasc Drug Discov     Country:  United Arab Emirates    
Other Details:
Languages:  eng     Pagination:  177-83     Citation Subset:  IM    
Heart Rhythm Management Centre, UZ Brussel-VUB, Brussels, Belgium.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Atrial Fibrillation / surgery,  therapy*
Balloon Dilation / methods*
Catheter Ablation / methods*
Cryosurgery / methods*
Pulmonary Veins / surgery
Treatment Outcome

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Ticagrelor and prasugrel: two novel, most-promising antiplatelet agents.
Next Document:  Prevention of left ventricular remodelling after acute myocardial infarction: an update.